Table 10. Overlap DE genes in human and monkey PBMCs after LPS stimulation.

GO term (P value)	Overlap DEGs (FC: h/m)	UniqH DEGs	UniqM DEGs
Immune response: (Ph =3.33×10–16); (Pm =8.88×10–7)	C1QC (0.1/0.4); CCL3 (2.5/2.2); CD74 (0.4/5.2); CXCL3 (7.0/2.7); IL1A (5.4/2.5); IL8 (6.4/2.0)	AQP9, C3, CCL13, CCL3L3, CCR2, CD276, CIITA, CMKLR1, CTSC, CTSS, CTSW, CXCL1, CXCL10, CXCL2, CXCL5, CXCL9, ENPP2, FCAR, FCGRT, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, IFI6, IGSF6, IL18, IL1B, IL6, LST1, NCF4, OAS1, OAS3, P2RY14, PDCD1LG2, PGLYRP1, PPBP, SECTM1, TLR4	B2M, CCL18, CCL4L1, CCL5, LOC100424348, LOC100427798, LOC694372, LOC714964, LOC720309, LOC720330, LOC720365, LOC722711, MAMU-A, MAMU-AG, MAMU-B, MAMU-B18, MAMU-DPA, MAMU-DPB, MAMU-DQA1, MAMU-DQB1, MAMU-DRA, MAMU-E, MAMU-F, MAMU-I, MAMU_DMA
Cytokine–mediated signaling pathway: (Ph =1.11×10–11); (Pm =0.003845)	CD74 (0.4/5.2); IL1A (5.4/2.5)	CCL2, CCR2, CEBPA, CIITA, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, IFI27, IFI30, IFI6, IFNG, IL1B, IL6, IRF5, JAK2, MT2A, MX1, OAS1, OAS3, SOCS3	IL2RG, JAK1
Chemotaxis: (Ph =1.11×10–11); (Pm =0.00647)	CCL3 (2.5/2.2); IL8 (6.4/2.0)	C3AR1; CCL13; CCL2; CCL3L3; CCR2; CMKLR1; CXCL1; CXCL10; CXCL16; CXCL2; CXCL3; CXCL5; CXCL9; ENPP2; FPR2; FPR3; PLAU; PLAUR	LOC721048
Inflammatory response: (Ph =1.58×10–10); (Pm =0.002622)	CCL3 (2.5/2.2); IL1A (5.4/2.5); IL8 (6.4/2.0)	C3, C3AR1, CCL13, CCL2, CCL3L3, CCR2, CD163, CLEC7A, CXCL1, CXCL10, CXCL2, CXCL3, CXCL9, FPR2, GGT5, IL1B, IL6, IRAK2, MMP25, NFKBIZ, SIGLEC1, SPP1, STAB1, TNFAIP6	CCL5

FC, fold change; Ph, P value of human; Pm, P value of monkey; h/m, human/monkey.